ScinoPharm has emphasised its compliance with waste water treatment rules, weeks after being contracted to supply API for Melinta Therapeutics’ antibiotic Baxdela.
API makers that don’t treat wastewater to cut costs and keep prices low are spreading antibiotic resistance says DSM-Sinochem, which wants drug companies to stop buying from firms that “distort” the market.
Pollution caused by pharmaceuticals in wastewater is a major challenge facing the industry, but researchers in Greece may have come up with a solution.
API firms that invest in waste management find it hard to compete with those that pollute according to DSM Sinochem, which wants environmental criteria included in GMP standards for environmental and business reasons.
Drugmakers risk losing financial backing if they source APIs from Indian suppliers that pollute according to Nordea Asset Management's head of responsible investments, Sasja Beslik.
Researchers have estimated that a pharmaceutical waste water treatment plant is pumping up to 45kg a day of ciprofloxacin into an Indian river, which could have grave consequences for the ecosystem.
The excessive use of a popular influenza drug, and the
associated build up of its waste in the environment, is
heightening the risk of creating viruses in nature that are
resistance to the therapy.
In an incident that state and federal environmental regulators are
treating as "serious," Merck released 25 gallons of a
cyanide-containing chemical from its West Point facility in
Pennsylvania to the sewer, killing hundreds...
A dual-stage membrane bioreactor (MBR) for advanced treatment of
industrial wastewater takes up less space and has lower operating
costs than conventional activated sludge processing systems.
UK study finds sewage treatment is effective in removing
pharmaceutical and personal care product chemicals,although there
some facilities are better than others.
